Biodefense Market
Biodefense Market: Global Industry Analysis 2017-2022 and Opportunity Assessment 2023-2033
A recent market study published by FMI on Biodefense offers a global industry analysis for 2017-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Product:
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Executive Summary
The executive summary of the Biodefense Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Biodefense Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Biodefense Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Biodefense Market Demand Analysis 2017-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 15.20 billion) analysis (2017-2022) and current and future market value (US$ 16.31 billion) and volume (7.3%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Biodefense Market - Pricing Analysis
Based on By Product, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Biodefense Market Analysis 2017-2022 and Forecast 2023-2033, By Product
Based on By Product, Biodefense Market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product.
Chapter 06 - Biodefense Market Analysis 2017-2022 and Forecast 2023-2033, By Region
Based on By Region, Biodefense Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 07 - North America Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 08 - Latin America Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Biodefense Market in the Latin America region.
Chapter 09 - Europe Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Biodefense Market in the regional market.
Chapter 10 - East Asia Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Biodefense Market in the regional market.
Chapter 11 - South Asia Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Biodefense Market in the regional market.
Chapter 12 - Middle East and Africa Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Biodefense Market in the regional market.
Chapter 13 - Key Countries Biodefense Market Analysis 2017-2022 and Forecast 2023-2033
This chapter offers insights into how the Biodefense Market is expected to grow in major countries globally.
Chapter 14 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 15 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are XOMA Corporation, Altimmune Inc., Emergent Biosolutions Inc., Dynavax Technologies Corporation, SIGA Technologies, Elusys Therapeutics Inc, Ichor Medical Systems, Dynport Vaccine Company, Cleveland Biolabs, Bavarian Nordic, Ology Bioservices, Alnylam Pharmaceuticals Inc.
Chapter 16 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 17 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Biodefense Market.
- 1. Executive Summary | Biodefense Market
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
- 5.3.1. Anthrax Biodefense
- 5.3.2. Botulism Biodefense
- 5.3.3. Smallpox Biodefense
- 5.3.4. Cholera Biodefense
- 5.3.5. Influenza Biodefense
- 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
- 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
- 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
- 6.3.1. Hospitals and Clinics
- 6.3.2. Ambulatory Care Centres
- 6.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
- 6.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
- 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. South Asia
- 7.3.5. East Asia
- 7.3.6. Oceania
- 7.3.7. MEA
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 8.2.1. By Country
- 8.2.1.1. USA
- 8.2.1.2. Canada
- 8.2.2. By Type
- 8.2.3. By End-User
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Type
- 8.3.3. By End-User
- 8.4. Key Takeaways
- 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Rest of Latin America
- 9.2.2. By Type
- 9.2.3. By End-User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By End-User
- 9.4. Key Takeaways
- 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. United Kingdom
- 10.2.1.3. France
- 10.2.1.4. Spain
- 10.2.1.5. Italy
- 10.2.1.6. Rest of Europe
- 10.2.2. By Type
- 10.2.3. By End-User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By End-User
- 10.4. Key Takeaways
- 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 11.2.1. By Country
- 11.2.1.1. India
- 11.2.1.2. Malaysia
- 11.2.1.3. Singapore
- 11.2.1.4. Thailand
- 11.2.1.5. Rest of South Asia
- 11.2.2. By Type
- 11.2.3. By End-User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Type
- 11.3.3. By End-User
- 11.4. Key Takeaways
- 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 12.2.1. By Country
- 12.2.1.1. China
- 12.2.1.2. Japan
- 12.2.1.3. South Korea
- 12.2.2. By Type
- 12.2.3. By End-User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Type
- 12.3.3. By End-User
- 12.4. Key Takeaways
- 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 13.2.1. By Country
- 13.2.1.1. Australia
- 13.2.1.2. New Zealand
- 13.2.2. By Type
- 13.2.3. By End-User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Type
- 13.3.3. By End-User
- 13.4. Key Takeaways
- 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
- 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
- 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
- 14.2.1. By Country
- 14.2.1.1. GCC Countries
- 14.2.1.2. South Africa
- 14.2.1.3. Israel
- 14.2.1.4. Rest of MEA
- 14.2.2. By Type
- 14.2.3. By End-User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Type
- 14.3.3. By End-User
- 14.4. Key Takeaways
- 15. Key Countries Market Analysis
- 15.1. USA
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2022
- 15.1.2.1. By Type
- 15.1.2.2. By End-User
- 15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2022
- 15.2.2.1. By Type
- 15.2.2.2. By End-User
- 15.3. Brazil
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2022
- 15.3.2.1. By Type
- 15.3.2.2. By End-User
- 15.4. Mexico
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2022
- 15.4.2.1. By Type
- 15.4.2.2. By End-User
- 15.5. Germany
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2022
- 15.5.2.1. By Type
- 15.5.2.2. By End-User
- 15.6. United Kingdom
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2022
- 15.6.2.1. By Type
- 15.6.2.2. By End-User
- 15.7. France
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2022
- 15.7.2.1. By Type
- 15.7.2.2. By End-User
- 15.8. Spain
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2022
- 15.8.2.1. By Type
- 15.8.2.2. By End-User
- 15.9. Italy
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2022
- 15.9.2.1. By Type
- 15.9.2.2. By End-User
- 15.10. India
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2022
- 15.10.2.1. By Type
- 15.10.2.2. By End-User
- 15.11. Malaysia
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2022
- 15.11.2.1. By Type
- 15.11.2.2. By End-User
- 15.12. Singapore
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2022
- 15.12.2.1. By Type
- 15.12.2.2. By End-User
- 15.13. Thailand
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2022
- 15.13.2.1. By Type
- 15.13.2.2. By End-User
- 15.14. China
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2022
- 15.14.2.1. By Type
- 15.14.2.2. By End-User
- 15.15. Japan
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2022
- 15.15.2.1. By Type
- 15.15.2.2. By End-User
- 15.16. South Korea
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2022
- 15.16.2.1. By Type
- 15.16.2.2. By End-User
- 15.17. Australia
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2022
- 15.17.2.1. By Type
- 15.17.2.2. By End-User
- 15.18. New Zealand
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2022
- 15.18.2.1. By Type
- 15.18.2.2. By End-User
- 15.19. GCC Countries
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2022
- 15.19.2.1. By Type
- 15.19.2.2. By End-User
- 15.20. South Africa
- 15.20.1. Pricing Analysis
- 15.20.2. Market Share Analysis, 2022
- 15.20.2.1. By Type
- 15.20.2.2. By End-User
- 15.21. Israel
- 15.21.1. Pricing Analysis
- 15.21.2. Market Share Analysis, 2022
- 15.21.2.1. By Type
- 15.21.2.2. By End-User
- 16. Market Structure Analysis
- 16.1. Competition Dashboard
- 16.2. Competition Benchmarking
- 16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Type
- 16.3.3. By End-User
- 17. Competition Analysis
- 17.1. Competition Deep Dive
- 17.1.1. XOMA corporation
- 17.1.1.1. Overview
- 17.1.1.2. Product Portfolio
- 17.1.1.3. Profitability by Market Segments
- 17.1.1.4. Sales Footprint
- 17.1.1.5. Strategy Overview
- 17.1.1.5.1. Marketing Strategy
- 17.1.2. Altimmune Inc.
- 17.1.2.1. Overview
- 17.1.2.2. Product Portfolio
- 17.1.2.3. Profitability by Market Segments
- 17.1.2.4. Sales Footprint
- 17.1.2.5. Strategy Overview
- 17.1.2.5.1. Marketing Strategy
- 17.1.3. Emergent Biosolutions Inc.
- 17.1.3.1. Overview
- 17.1.3.2. Product Portfolio
- 17.1.3.3. Profitability by Market Segments
- 17.1.3.4. Sales Footprint
- 17.1.3.5. Strategy Overview
- 17.1.3.5.1. Marketing Strategy
- 17.1.4. Dynavax Technologies Corporation.
- 17.1.4.1. Overview
- 17.1.4.2. Product Portfolio
- 17.1.4.3. Profitability by Market Segments
- 17.1.4.4. Sales Footprint
- 17.1.4.5. Strategy Overview
- 17.1.4.5.1. Marketing Strategy
- 17.1.5. SIGA Technologies.
- 17.1.5.1. Overview
- 17.1.5.2. Product Portfolio
- 17.1.5.3. Profitability by Market Segments
- 17.1.5.4. Sales Footprint
- 17.1.5.5. Strategy Overview
- 17.1.5.5.1. Marketing Strategy
- 17.1.6. Elusys Therapeutics Inc.
- 17.1.6.1. Overview
- 17.1.6.2. Product Portfolio
- 17.1.6.3. Profitability by Market Segments
- 17.1.6.4. Sales Footprint
- 17.1.6.5. Strategy Overview
- 17.1.6.5.1. Marketing Strategy
- 17.1.7. Ichor Medical Systems.
- 17.1.7.1. Overview
- 17.1.7.2. Product Portfolio
- 17.1.7.3. Profitability by Market Segments
- 17.1.7.4. Sales Footprint
- 17.1.7.5. Strategy Overview
- 17.1.7.5.1. Marketing Strategy
- 17.1.8. Dynport Vaccine Company.
- 17.1.8.1. Overview
- 17.1.8.2. Product Portfolio
- 17.1.8.3. Profitability by Market Segments
- 17.1.8.4. Sales Footprint
- 17.1.8.5. Strategy Overview
- 17.1.8.5.1. Marketing Strategy
- 17.1.9. Cleveland Biolabs.
- 17.1.9.1. Overview
- 17.1.9.2. Product Portfolio
- 17.1.9.3. Profitability by Market Segments
- 17.1.9.4. Sales Footprint
- 17.1.9.5. Strategy Overview
- 17.1.9.5.1. Marketing Strategy
- 17.1.10. Bavarian Nordic.
- 17.1.10.1. Overview
- 17.1.10.2. Product Portfolio
- 17.1.10.3. Profitability by Market Segments
- 17.1.10.4. Sales Footprint
- 17.1.10.5. Strategy Overview
- 17.1.10.5.1. Marketing Strategy
- 17.1.11. Ology Bioservices.
- 17.1.11.1. Overview
- 17.1.11.2. Product Portfolio
- 17.1.11.3. Profitability by Market Segments
- 17.1.11.4. Sales Footprint
- 17.1.11.5. Strategy Overview
- 17.1.11.5.1. Marketing Strategy
- 17.1.12. Alnylam Pharmaceuticals Inc
- 17.1.12.1. Overview
- 17.1.12.2. Product Portfolio
- 17.1.12.3. Profitability by Market Segments
- 17.1.12.4. Sales Footprint
- 17.1.12.5. Strategy Overview
- 17.1.12.5.1. Marketing Strategy
- 18. Assumptions & Acronyms Used
- 19. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook